News brief
On September 16, 2026, Shanghai-based Anew Labs, an AI drug discovery platform spun off from ByteDance, raised USD 290 million in its first external round co-led by HSG Sequoia China, IDG Capital, Hillhouse Ventures and 5Y Capital, at a USD 1.5 billion valuation.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.reuters.com ↗Published Sep 16, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月16日，据路透社报道，上海AI药物发现及研发平台Anew Labs完成2.9亿美元首次外部融资，HSG红杉中国、IDG资本、高瓴创投、五源资本共同领投，估值15亿美元。公司为字节跳动药研业务分拆。